Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Aisner

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 7, 2018
Daily Image Guidance With Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung CancerNikhil Yegya-Raman, Sinae Kim, Matthew P Deek, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2005
A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignanciesDale Schaar, Lauri Goodell, Joseph Aisner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancyEdward J Licitra, Viral Vyas, Kathy Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinomaRoger K Strair, Dale Schaar, Daniel Medina, et al.
Cancer Chemotherapy and Pharmacology|August 30, 2019
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumorsJanice M Mehnert, Amanda D Kaveney, Jyoti Malhotra, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2021
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignanciesAntoinette R Tan, Nancy Chan, Brian F Kiesel, et al.
Oncotarget|April 10, 2023
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850Kristen R Spencer, Daniella E Portal, Joseph Aisner, et al.
Journal of Thoracic Disease|July 10, 2020
Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancerDakim K Gaines, Nikhil Yegya-Raman, Sinae Kim, et al.
JCO Precision Oncology|September 25, 2018
Inference of Germline Mutational Status and Evaluation of Loss of Heterozygosity in High-Depth, Tumor-Only Sequencing DataHossein Khiabanian, Kim M Hirshfield, Mendel Goldfinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant RegistryDonald A Berry, Gloria Broadwater, John P Klein, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|May 7, 2018
Daily Image Guidance With Cone Beam Computed Tomography May Reduce Radiation Pneumonitis in Unresectable Non-Small Cell Lung CancerNikhil Yegya-Raman, Sinae Kim, Matthew P Deek, et al.
Cancer Chemotherapy and Pharmacology|October 19, 2005
A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignanciesDale Schaar, Lauri Goodell, Joseph Aisner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003
Phase I evaluation of sequential topoisomerase targeting with irinotecan/cisplatin followed by etoposide in patients with advanced malignancyEdward J Licitra, Viral Vyas, Kathy Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
Antineoplastic effects of partially HLA-matched irradiated blood mononuclear cells in patients with renal cell carcinomaRoger K Strair, Dale Schaar, Daniel Medina, et al.
Cancer Chemotherapy and Pharmacology|August 30, 2019
A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumorsJanice M Mehnert, Amanda D Kaveney, Jyoti Malhotra, et al.
Cancer Chemotherapy and Pharmacology|October 20, 2021
A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignanciesAntoinette R Tan, Nancy Chan, Brian F Kiesel, et al.
Oncotarget|April 10, 2023
A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850Kristen R Spencer, Daniella E Portal, Joseph Aisner, et al.
Journal of Thoracic Disease|July 10, 2020
Tumor volume reduction evaluated by cone beam computed tomography during stereotactic body radiotherapy for early stage non-small cell lung cancerDakim K Gaines, Nikhil Yegya-Raman, Sinae Kim, et al.
JCO Precision Oncology|September 25, 2018
Inference of Germline Mutational Status and Evaluation of Loss of Heterozygosity in High-Depth, Tumor-Only Sequencing DataHossein Khiabanian, Kim M Hirshfield, Mendel Goldfinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
High-dose versus standard chemotherapy in metastatic breast cancer: comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant RegistryDonald A Berry, Gloria Broadwater, John P Klein, et al.
Pageof 7